Literature DB >> 7739893

Protein-peptide interactions analyzed with the yeast two-hybrid system.

M Yang1, Z Wu, S Fields.   

Abstract

The yeast two-hybrid system was used to screen a library of random peptides fused to a transcriptional activation domain in order to identify peptides capable of binding to the retinoblastoma protein (Rb). Seven peptides were identified, all of which contain the Leu-X-Cys-X-Glu motif found in Rb-binding proteins, although their activity in the yeast assay varied over a 40-fold range. Mutagenesis of the DNA encoding two of these peptides followed by screening in the two-hybrid system allowed the delineation of residues apart from the invariant Leu, Cys and Glu that affect binding to Rb. Binding affinities of a peptide and one of its variants to Rb, determined by surface plasmon resonance, correlated with results from the two-hybrid assay. This method offers several advantageous features compared to existing technology for screening peptide libraries: in vivo detection of protein-peptide interactions, high sensitivity, the capacity for rapid genetic screening to identify stronger and weaker binding peptide variants, and the use of a simple assay (transcriptional activity) as a means to assess binding affinity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7739893      PMCID: PMC306824          DOI: 10.1093/nar/23.7.1152

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  22 in total

1.  Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor.

Authors:  M G Cull; J F Miller; P J Schatz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

3.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  Random peptide libraries: a source of specific protein binding molecules.

Authors:  J J Devlin; L C Panganiban; P E Devlin
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

5.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

Authors:  J A DeCaprio; J W Ludlow; D Lynch; Y Furukawa; J Griffin; H Piwnica-Worms; C M Huang; D M Livingston
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

6.  A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.

Authors:  E Moran
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  The binding domain structure of retinoblastoma-binding proteins.

Authors:  J Figge; K Breese; S Vajda; Q L Zhu; L Eisele; T T Andersen; R MacColl; T Friedrich; T F Smith
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

Review 8.  The two-hybrid system: an assay for protein-protein interactions.

Authors:  S Fields; R Sternglanz
Journal:  Trends Genet       Date:  1994-08       Impact factor: 11.639

9.  Peptides on phage: a vast library of peptides for identifying ligands.

Authors:  S E Cwirla; E A Peters; R W Barrett; W J Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

View more
  34 in total

1.  The zinc finger-associated SCAN box is a conserved oligomerization domain.

Authors:  A J Williams; S C Blacklow; T Collins
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Isolation of peptide aptamers that inhibit intracellular processes.

Authors:  J H Blum; S L Dove; A Hochschild; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.

Authors:  Eléonore Real; Jean-Christophe Rain; Véronique Battaglia; Corinne Jallet; Pierre Perrin; Noël Tordo; Peggy Chrisment; Jacques D'Alayer; Pierre Legrain; Yves Jacob
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  A method for generation of arbitrary peptide libraries using genomic DNA.

Authors:  Haiming Huang; Youhe Gao
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

5.  Interaction trap/two-hybrid system to identify interacting proteins.

Authors:  E A Golemis; I Serebriiskii; R L Finley; M G Kolonin; J Gyuris; R Brent
Journal:  Curr Protoc Cell Biol       Date:  2001-05

6.  A potentially general method for the in vivo selection of inhibitory peptides targeted at a specific protein using yeast.

Authors:  Jacques H Daniel
Journal:  Curr Genet       Date:  2008-05-14       Impact factor: 3.886

7.  Prediction of functional regions of the maize streak virus replication-associated proteins by protein-protein interaction analysis.

Authors:  G V Horváth; A Pettkó-Szandtner; K Nikovics; M Bilgin; M Boulton; J W Davies; C Gutiérrez; D Dudits
Journal:  Plant Mol Biol       Date:  1998-11       Impact factor: 4.076

8.  Targeting cyclin-dependent kinases in Drosophila with peptide aptamers.

Authors:  M G Kolonin; R L Finley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  A three-hybrid system to detect RNA-protein interactions in vivo.

Authors:  D J SenGupta; B Zhang; B Kraemer; P Pochart; S Fields; M Wickens
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

10.  Use of the two-hybrid system to identify protein-protein interaction temperature-sensitive mutants: application to the CDK2/p21Cip1 interaction.

Authors:  C Cayrol; G Cabrolier; B Ducommun
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.